GlassScriptPhysician profile
George B Ramie
NPI 1518942317
$2,354.99
in general payments reported to CMS, 2019-2025
16 companies · $1,453 in 2025
The $1,453 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $58.53 · 2021: $277 · 2022: $166 · 2023: $217 · 2024: $62.09 · 2025: $1,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $850 · Travel and Lodging: $563 · Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $849.99 |
| Travel and Lodging | $562.65 |
| Food and Beverage | $319.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,357.11 | 2025 | |
| Astellas Pharma US INC | $378.45 | 2020-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $210.34 | 2019-2023 | |
| Aspira Women'S Health INC | $85.45 | 2021 | |
| Pfizer INC. | $67.05 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.57 | 2019-2022 | |
| Caldera Medical, INC | $35.99 | 2021 | |
| Duchesnay USA Incorporated | $31.08 | 2019 | |
| Exeltis, USA INC. | $27.87 | 2022-2024 | Slynd |
| Sage Therapeutics, LLC | $23.05 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $21.45 | 2022 | |
| Roche Diagnostics Corporation | $16.68 | 2019 | |
| Olympus America INC. | $14.93 | 2025 | Evis Exera III Video System Center |
| Boston Scientific Corporation | $14.70 | 2025 | Solyx Sis System |
| Merck Sharp & Dohme LLC | $14.27 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Ramie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.